Healthcare & Life Sciences
Target Company
Bionostics, Inc.
Techne Corporation (NASDAQ:TECH)

Client Description:

Bionostics is a global leader in the development, manufacture, and distribution of control solutions that verify the proper operation of in vitro diagnostic (IVD) devices primarily utilized in point of care blood glucose and blood gas testing. The company recently launched coagulation control products and is developing new controls for other growing diagnostic uses, particularly controls for cholesterol and HbA1c devices. Bionostics is positioned to take advantage of continuing growth driven by the increasing prevalence of diabetes and other diseases, the migration of diagnostic testing from the laboratory to the operating room, bedside, clinic, and home points of care, the implementation of controls regulations in global markets, and new controls being required for emerging diagnostic products.